EUVIMEDEUVIMED entdecken
Crossref

Risdiplam: A Small Molecule mRNA Splice Modifier Approved to Treat SMA Disease

Lutz Müller, Björn Jacobsen iD, Alexander Nürnberg iD

Toxicologic Pathology · 2025-12 · 53 (8) · 695-699

DOI: 10.1177/01926233251392863 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicologic Pathology, online erschienen am 18.11.2025. Verfasst von Lutz Müller und 2 weiteren Autor:innen. Beteiligte Einrichtung: F. Hoffmann-La Roche Ltd, Basel, Switzerland. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: F. Hoffmann-La Roche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Risdiplam is the only approved small molecule mRNA splice modifier to date. Over more than five years since its first approval, thousands of patients with spinal muscular atrophy have benefited from risdiplam therapy. Yet, the nonclinical development of risdiplam was marked by toxicological challenges requiring new strategies and approaches, which ultimately translated into clinical success. This minireview covers key aspects of the nonclinical development of risdiplam, particularly focusing on its toxicological characterization and histopathological features in animal studies.

Schlagwörter

Stichwörter der Autor:innen

SMN2male germ cellsretinarisdiplamsecondary splice targetsspinal muscular atrophysplice modifier

Autor:innen und Institutionen

  • F. Hoffmann-La Roche Ltd, Basel, Switzerland.

ORCID-Profile: Björn Jacobsen, Alexander Nürnberg

Förderung

  • F. Hoffmann-La Roche

Zitieren

APA

Müller, L., Jacobsen, B., & Nürnberg, A. (2025). Risdiplam: A Small Molecule mRNA Splice Modifier Approved to Treat SMA Disease. Toxicologic Pathology, 53(8), 695-699. https://doi.org/10.1177/01926233251392863

Vancouver

Müller L, Jacobsen B, Nürnberg A. Risdiplam: A Small Molecule mRNA Splice Modifier Approved to Treat SMA Disease. Toxicologic Pathology. 2025;53(8):695-699. doi:10.1177/01926233251392863

BibTeX
@article{Mller2025,
  author = {Müller, Lutz and Jacobsen, Björn and Nürnberg, Alexander},
  title = {Risdiplam: A Small Molecule mRNA Splice Modifier Approved to Treat SMA Disease},
  journal = {Toxicologic Pathology},
  year = {2025},
  volume = {53},
  number = {8},
  pages = {695--699},
  doi = {10.1177/01926233251392863}
}
Kostenlos starten →